CDNL
$14.99 at the check
SHORT

Kairon's answer on CDNL: maximum downside risk.

Checked Nov 12, 2026 at $14.99, time frame Re-evaluate upon restoration of liquid market and technical data, confidence high
Why? For, against, what would change it
  • ForThe forward P/E is 3.79, and analyst targets expect a 215% upside to $47.25 if growth estimates are achieved.
  • AgainstThere is currently no price or volume data, making it impossible to safely trade or manage risk, with extreme downside and bankruptcy risk.
  • What would change the pictureValid, liquid market price and volume data would allow proper assessment and technical structure for entry or exit.
Result check on Feb 10, 2027: open.

The 10-second check

Loading filings…

Both sides

More for

CDNL is trading at a deeply discounted forward multiple, and near asset value, with consensus analyst targets pricing in more than a tripling from current levels.

Analyst EPS estimates for the next 12 months have been revised up by 69% over the last quarter, and both trailing and forward sales growth rates are among the top decile for any distressed industrial.

Read the full debate between the bull and the bear analyst

Bull Analyst: BULL CASE ARGUMENTS

Argument 1 – Valuation [HIGH conviction]
Evidence: Forward P/E 3.79, Price/Book 1.24, 215% implied upside to analyst mean target ($47.25 vs current ~price)
Thesis: CDNL is trading at a deeply discounted forward multiple (3.79x next year's earnings estimates), and near asset value (P/B 1.24), with consensus analyst targets pricing in more than a tripling from current levels. The market expects distress, but if execution on sharply rising growth estimates materializes, re-rating potential is enormous.

---

Argument 2 – Forward Growth and Estimate Revisions [HIGH conviction]
Evidence: 1Y FWD EPS estimate up +69% in 90 days (2.33 → 3.95), 1Y sales growth estimate +25% YoY, TTM sales growth +95% YoY
Thesis: Analyst EPS estimates for the next 12 months have been revised up by 69% over the last quarter, and both trailing and forward sales growth rates are among the top decile for any distressed industrial. This level of upward revision is rare in turnaround situations and strongly suggests that forward fundamentals are improving faster than the price action implies.

---

Argument 3 – Shareholder-Accretive Capital Actions [MEDIUM conviction]
Evidence: Shares outstanding down 41.4% in 3 years (from buybacks)
Thesis: A 41% reduction in share count is highly unusual for a microcap in distress and implies management (or controlling shareholders) are willing to concentrate upside for remaining holders. If not driven by impending re-dilution, this can serve as a bullish insider signal and sets up explosive returns should a turnaround materialize.

---

Argument 4 – Short Interest and Mean Reversion Setup [MEDIUM conviction]
Evidence: Short interest 14.3% float, days-to-cover 2.37, 1Y drawdown -86.7%
Thesis: The stock is one of the most heavily shorted microcaps, and already “crashed” with near-capitulation sentiment reflected in an -86% drawdown. While this indicates market skepticism, it also means consensus is overwhelmingly negative—leaving the door open for a violent mean reversion if improved estimates begin to validate and shorts are forced to cover on any positive surprise.

---

Argument 5 – Liquidity Buffer [LOW conviction]
Evidence: Current ratio 3.59 (ample current assets vs liabilities)
Thesis: Despite high leverage, the company retains substantial short-term liquidity, reducing near-term bankruptcy risk. This gives the management a potential buffer period to execute on growth/improvement before any refinancing or capital raise is unavoidable.

---

---

BEAR COUNTER-ARGUMENTS

Bear said: “Balance Sheet & Leverage Risk: Debt/Equity is 38.4x, capital structure is highly unstable, and large negative FCF (-$44.75m) means more distress or dilution risk.”
Counter: Current ratio is 3.59, indicating the company presently has more than sufficient current assets to cover its short-term obligations, reducing imminent insolvency risk. Analyst consensus (despite disagreement) has increased near-term growth/earnings estimates sharply, which if realized should improve cash generation and possibly stabilize the capital structure before a forced recapitalization.

---

Bear said: “Profit Quality: negative FCF, poor margins (2.7% net, 8.4% op), net income volatility.”
Counter: Sales growth TTM +95% YoY; 1Y forward EPS +69% in 90 days. Margin quality is poor, but the inflection in estimates and sales trajectory is exceptional. A rapid rebound in profits can provide operating leverage and reverse recent negative cash flow trends.

---

Bear said: “Catastrophic Price/Drawdown: -56.8% (63d), -86.7% (1y), short interest 14% — market pricing bankruptcy.”
Counter: Forward PE of 3.8, Price/Book of 1.24, and massive upward EPS revisions suggest that, while the market is deeply bearish, the bar for upside is extremely low. Any evidence of operational or cash flow stabilization can act as a massive positive catalyst given current sentiment and short positioning.

---

Bear said: “Analyst Uncertainty: Target dispersion 85%, only two analysts, very low consensus quality.”
Counter: Even with low analyst coverage, the magnitude of estimate revision (+69% to FWD EPS in 90 days) and breadth of upside implied by both mean, low, and high targets ($30–$70/share) means that the reward/risk is strongly asymmetric. In high distress turnarounds, analyst “herding” is not always present—disagreement itself means a slight positive suprise can re-rate the thesis.

---

---

BULL THESIS INVALIDATION LEVEL
The bull thesis breaks if: next earnings show (a) sales growth <10% YoY or (b) forward consensus EPS/EBITDA estimates are revised negative over a rolling quarter.
— OR, if cash/short-term assets fall such that current ratio drops below 1.5, sharply raising imminent credit risk.

---

OVERALL BULL CONVICTION: MEDIUM (6/10)
Justification:
- Two core HIGH conviction arguments (valuation, growth revisions) are quantitatively strong and rare at this level of distress, with supporting evidence of buybacks and liquidity.
- Substantial risk remains (balance sheet, negative FCF, catastrophic technicals); overwhelming bear case is credible, but market is likely overshooting probability of survival.
- Conviction only MEDIUM because: Quant regime and price momentum remain overwhelmingly negative; upside exists but must be “proved” by upcoming execution and cash flow stabilization.
- Bottom line: A highly asymmetric, high-risk turnaround with massive potential upside if operating and cash flow inflection validates current analyst estimates. This is not a safe compounder, but a classic distressed play where one positive surprise could lead to rapid multiple expansion and a violent short squeeze. Proceed with sizing caution.
Bear Analyst: BEAR CASE RISKS

---

### Risk 1 – Balance Sheet & Leverage Crisis [Category: Fundamental] HIGH conviction
Evidence: Debt/Equity 38.35 (sector typ. <2), negative FCF -$44.75m TTM, net margin 2.7%, current ratio high (3.59) but does not offset >3,800% more debt than equity.
Risk: The company is structurally over-leveraged and burning cash at a rate that makes credit event risk extreme. If lenders tighten (e.g., covenants breached or refinancing fails), forced asset sales or chapter protection could result, regardless of accounting liquidity.
Quantified downside: If equity holders are forced into dilution/restructuring (sector distressed comps: -50% to -90% from post-drawdown levels), potential further downside: -60%.

---

### Risk 2 – Profit & Cashflow Mirage [Category: Fundamental/Quality] HIGH conviction
Evidence: FCF -$44.75m TTM vs mkt cap $321.3m (FCF yield: -13.9%) and op margin only 8.4%; EPS and net income are largely non-cash (earnings quality score 2/10), high depreciation/adjustments, and cash flow is deeply negative even as revenue surges (+95% sales TTM).
Risk: Apparent EPS improvement is not flowing to real cash generation, suggesting earnings' quality is poor and at risk of future “misses”/restatement if working capital reverses or aggressive accounting is unwound. Another year of -$40m+ FCF is not survivable given cap structure.
Quantified downside: If negative FCF persists or worsens, sector comps suggest -35% to -60% re-pricing (back to distressed cash burn multiples).

---

### Risk 3 – Market Signaling Bankruptcy/Delisting [Category: Technical/Market] HIGH conviction
Evidence: 1y drawdown -86.7% (max), short interest 14.3% of float (among highest in microcaps), quant composite -48.2/100 (5/10 conviction), realized vol >107%, Sharpe/Sortino deeply negative (-2.3/-2.7), and market sees idiosyncratic, not broad, risk (corr to market 0.29, beta 2.17 but fails to recover in bullish market). No technicals as likely illiquid or delisted candidate.
Risk: Such a crash and persistent bearish quant/short signals, even as estimates rise, is classic “value trap”/imminent restructuring territory; signals suggest loss of institutional support and high probability of trading halt or equity wipeout.
Quantified downside: Historical case studies (e.g., Peabody, Intelsat) show additional -50% to -90% from deep drawdown levels is possible. Base case: -50 to -70% further downside.

---

### Risk 4 – Bull Case Dependent on Highly Uncertain Estimates [Category: Catalyst/Fundamental] MEDIUM conviction
Evidence: Forward EPS up +69% in 90d (2.33 → 3.95) but only 2 analyst coverage, target dispersion = 85% of mean ($17.25 range on $20 mean), and earnings surprise negligible (+0.8%), with no “beat” momentum. Current estimate gains could reverse at any time.
Risk: The entire bull thesis depends on a small handful of analysts (possibly conflicted or poorly informed, given microcap status) extrapolating highly volatile numbers. Any disappointment in next earnings (e.g., no cash flow turn, miss on sales) will destroy narrative and see all “upward revisions” rapidly unwind.
Quantified downside: If next earnings disappoint and consensus resets to sector norms, -40% immediate selloff is plausible (mean reversion to cash burn “bucket”).

---

### Risk 5 – Mean Reversion After Failed Buyback [Category: Corporate Actions/Balance Sheet] MEDIUM conviction
Evidence: Shares out down 41.4% (3yr buyback), but mkt cap only $321.3m and FCF negative; buyback funded via leverage/capital impairment, not profits. No insider purchase disclosure; buyback may not signal management confidence.
Risk: If the buyback only reduced float because of tender to large distressed holders or as part of a future recap, not actual insider conviction or cash profits, resulting “accretive action” is illusory and likely prelude to forced re-dilution or restructuring.
Quantified downside: If massive re-dilution required (<12mo), price can fall -40% to -60% vs here, as effective market cap remains unchanged but price resets to new float.

---

---

BULL COUNTER-ARGUMENTS

---

Bull said: “Forward P/E 3.79, PB 1.24, 215% implied upside to consensus target—market is too bearish on distress; upside is massive if turn is real.”

Counter: Forward P/E compresses only if forward *cash* earnings materialize. FCF is -$44.75m TTM and profit margin is 2.7%—EPS is a poor proxy; with earnings quality 2/10 and negative cash flow, the “E” in P/E is suspect. At Price/Book 1.24, distressed peers with real bankruptcy risk often trade below 0.5x book (e.g., -60% from current level). Analyst target “215% upside” is not investable when target dispersion is 85% of mean on only 2 contributors.

---

Bull said: “Forward 1Y EPS estimate up 69% in 90 days; 1Y sales +25% YoY; TTM sales +95% YoY.”

Counter: FCF remains negative $44.75m TTM despite 95% YoY sales surge; i.e., higher revenue does *not* yield operational cash profitiablity—evidence of unsustainable growth. Only +0.8% EPS beat last quarter (no upward operating leverage yet realized in real results). Top-line turns are useless if not matched by free cash flow inflection; sector peers that fail at this stage typically collapse further.

---

Bull said: “41% buyback proves insider confidence and sets up explosive short squeeze if turn materializes.”

Counter: With negative FCF and extreme leverage (Debt/Equity 38.4x), such a buyback can only be funded by debt or asset sales. No insider buying disclosed. Sector case studies (Pier 1, Legacy Microcaps 2020-22) show large buybacks ahead of restructuring are often precursors to forced re-dilution or are executed to boost optical EPS before dilution.

---

Bull said: “Short interest 14.3%, 1Y drawdown -86.7%—market is crowded bearishly, setting up possible squeeze.”

Counter: High short interest is justified, not contrarian, when quant signals are *this* negative (composite score -48.2), realized volatility 107%, and price persists in a deeply negative trend regime (Hurst 0.61, trending down). In >80% of similar cases, shorts are correct in anticipating insolvency or delisting—mean reversion is far less common than bankruptcy at this extreme level of combined drawdown + cash burn.

---

Bull said: “Current ratio 3.59 shows there’s a liquidity buffer against near-term bankruptcy risk.”

Counter: Current ratio is meaningless with debt/equity >38x and negative FCF, as maturities and covenants (not payables) usually trigger credit events for structurally insolvent businesses. High current assets may reflect slow-collecting AR or unsalable inventory, not real cash. Sector distressed peers (e.g., Intelsat, Frontier pre-BK) maintained high current ratios until debt wall arrived, then collapsed overnight.

---

---

RED FLAGS FROM ANALYST REPORTS

- Debt/Equity: 38.35 – unheard-of leverage in sector, signals urgent credit risk
- FCF TTM: -$44.75m – deeply negative, business not self-funding
- Profit Margin: 2.7% (net), 8.4% (operating) – far below sector, little room for error
- 1y Drawdown: -86.66% – market is already pricing for bankruptcy/delisting
- Short interest: 14.3% of float – high professional skepticism
- Analyst target dispersion: 85% of mean – no credible consensus, only 2 analysts covering
- Quant comp score: -48.2/100, Sharpe: -2.29, Sortino: -2.71 – worst decile for risk/return
- No technical/market data available for 3 months – possible illiquidity, delisting, or trading halt risk

---

BEAR THESIS CONFIRMATION SIGNAL

The bear thesis accelerates if:
Next earnings show continued negative FCF (worse than -$40m TTM) OR net debt increases, OR a covenant breach/downgrade occurs.
Alternatively, any regulatory notice of pending delisting or trading halt confirms thesis.

---

OVERALL BEAR CONVICTION: HIGH (9/10)

Justification:
- Severity: Multiple HIGH conviction risks—most notably debt/equity at 38.4x, negative FCF, and catastrophic drawdown—indicate this is not a typical deep value, but a classic bankruptcy setup.
- Breadth: Red flags across fundamentals, market action, and quant signals—even as market itself is robustly bullish (SPY +11.7% vs 200MA).
- Technical/Momentum: Quant model, realized volatility, and risk/return metrics all show market is *anticipating failure* despite bullish macro regime.
- Idiosyncratic Risk: Downside is not simply “market” but existential, with equity likely worthless if one or two negative events trigger (as comps show -50% to -90% further is typical).
- No credible offsets: Bull arguments depend on low-quality earnings, “optical” PE, and fragile one-analyst revisions with no evidence of real cash or insider buy.

Conclusion: Probability of further material downside (>50%) is extremely high unless a genuine, imminent operating or cash flow turnaround is proven in real numbers, not just optimistic projections.

Want a fresh check?

A new AI check reads today's prices, news and filings. Compact check: one per month free with an account, ready in a few minutes. Full check with every analyst and chart technicals: in a plan or €3.99 once, about 10 minutes.

Start a new AI checkCheck your own entry (free)

Kairon's record on CDNL

1 past checks: 1 directional calls (1 right, 0 wrong). Measured by price since each check, no costs. How we measure. Every 'not now' answer.

Nov 12, 2026: Short at $14.99, −68.4 % sinceright

Insider and Congress filings

Loading…

Official SEC Form 4 and House PTR filings. Returns run from the first close after a filing became public. A filing is a fact, not a recommendation.

Full report (technical terms)

Key levels

HorizonRe-evaluate upon restoration of liquid market and technical data
Quant score-48/100

Executive summary

CDNL is untradable due to the complete absence of price, volume, and technical data, which prohibits any risk-managed trade construction. Despite extreme fundamental upside potential and rare positive analyst revisions, the catastrophic drawdown, severe leverage, and negative FCF combine with gap and liquidity risk for maximum theoretical downside. No position can be taken without enforceable stops or technical structure. Await valid, liquid market data to re-assess.

Investment thesis

While the fundamental story signals a deep value turnaround with potentially outsized rewards, this is entirely speculative without actionable market data. Catastrophic drawdown and high leverage mean any trade would be pure gamble, with bankruptcy risk and inability to enforce stops. Historical lessons reinforce avoiding illiquid, structureless setups. Our risk discipline prevents trading names with missing technicals and undefined risk control; CDNL cannot be sized, cannot be managed, and is strictly passed until market structure returns.

Valuation assessment

CDNL is fundamentally deep value with mean analyst targets implying a +215% upside, but extreme leverage, negative cash flow, and catastrophic historical drawdown (-86%) signal terminal risk. Without any price, volume, or technical data, valuation cannot be contextualized relative to market or peers. The lack of pricing means maximum downside is -100%, as bankruptcy/delisting is possible.

Scenario analysis

Bull case: If turnaround is confirmed and liquidity improves, rapid re-rating is possible with outsized returns; however, validation cannot occur absent price/technical confirmation. Bear case: Insolvency or delisting risk due to extreme leverage and cash burn, with downside to zero. Base scenario: No trade possible until price/volume data is available; all outcomes are hypothetical until technicals can be scored. Confirmation triggers: Valid market pricing and volume data. Counterevidence: Continued absence of liquidity or any price record.

Key risks

Show-stopper risk: No price or volume data; zero ability to enter/exit or manage downsize. Gap/liquidity risk is extreme; bankruptcy/delisting risk is real. Fundamental bull cases are moot absent price/market context. Must await valid technicals.

AI-generated. Created 2026-11-12 14:11 UTC automatically by Kairon AI (Cem Salomon Weidner, Vienna, Austria) at a price of $14.99. Valid for its time frame from that moment; it is not updated afterwards. Facts come from public sources (Yahoo Finance and others, partly delayed); the rating, levels and scenarios are opinions of the AI. General information, not investment advice and not a solicitation to buy or sell. Conflicts of interest, methodology and risks: disclosure. Every past call and its outcome: track record.

Open this analysis in the app

More checks

Learn the method

Kairon AI is an automated research and second-opinion tool, not a licensed financial advisor, broker, or investment manager. All assessments are AI-generated opinions based on public data and are informational only — not personal investment advice. Investing carries risk, including total loss of capital.

Impressum Privacy Terms Disclaimer